KOURTNEY HOWARD: Open Payments
NPI 1275925000 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,789 in 149 payments from 28 companies in 2025. Trend: 2023 $1,807 · 2024 $2,526 · 2025 $2,789
Food & beverage: $2,789
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 22 | $452 |
| ABBVIE INC. | 19 | $338 |
| GlaxoSmithKline, LLC. | 23 | $270 |
| Novo Nordisk Inc | 14 | $225 |
| Otsuka America Pharmaceutical, Inc. | 8 | $184 |
| AstraZeneca Pharmaceuticals LP | 9 | $173 |
| Radius Health, Inc. | 6 | $157 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $113 |
| Sumitomo Pharma America, Inc. | 5 | $111 |
| Lundbeck LLC | 4 | $100 |
Products named: REXULTI, MOUNJARO, CREON, Tymlos, Wegovy, TRELEGY ELLIPTA, ZEPBOUND, XIFAXAN.
Industry payments across TX — which companies pay providers there.
